Outlook Therapeutics OTLK
NASDAQ OTLK
$0.58 +0.01 (+1.48%)
As of: Oct 1, 2026 · 3:59 PM EDT

Outlook Therapeutics (OTLK) Other Non-Current Assets (2015 - 2026)

Updated

Outlook Therapeutics' Other Non-Current Assets was $304,048 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 34.5% from $464,388 a year earlier and down 5.1% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Other Non-Current Assets (2015 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Other Non-Current Assets at Outlook Therapeutics came in at $417,523, down 5.0% from FY2024.

  • Other Non-Current Assets shows a five-year compound annual growth rate of -20.3% (FY2020 to FY2025).
  • In earlier fiscal years, Other Non-Current Assets was $439,283 in FY2024 (-12.4%), $501,299 in FY2023 (+279.7%), $132,015 in FY2022 (-24.4%) and $174,590 in FY2021 (-86.5%).
  • The fiscal Q3 2026 figure marks the lowest quarterly Other Non-Current Assets since fiscal Q2 2023.
  • Compared with a year earlier, Other Non-Current Assets has declined for nine straight quarters, with an average decline of 15.2% over the last eight quarters.
  • The best year-over-year quarter for Other Non-Current Assets over five years was fiscal Q3 2023 (growth of 319.9%); the worst was fiscal Q2 2022 (a decline of 86.8%).
  • Per Business Quant data, OTLK's Other Non-Current Assets in the three fiscal quarters before Q3 2026 was $320,290 (Q2 2026), $346,111 (Q1 2026) and $417,523 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Outlook Therapeutics 77.94 Mn 42.19 Mn -8,265.00 304,048.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 304,048.00
Mar 31, 2026 320,290.00
Dec 31, 2025 346,111.00
Sep 30, 2025 417,523.00
Jun 30, 2025 464,388.00
Mar 31, 2025 393,831.00
Dec 31, 2024 415,974.00
Sep 30, 2024 439,283.00
Jun 30, 2024 479,229.00
Mar 31, 2024 473,241.00
Dec 31, 2023 484,320.00
Sep 30, 2023 501,299.00
Jun 30, 2023 589,365.00
Mar 31, 2023 113,850.00
Dec 31, 2022 126,442.00
Sep 30, 2022 132,015.00
Jun 30, 2022 140,356.00
Mar 31, 2022 141,859.00
Dec 31, 2021 156,702.00
Sep 30, 2021 174,590.00
API Access

Outlook Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=OTLK&period=max&api_key=YOUR_API_KEY